VC  Catalytic Impact Foundation

https://www.cifimpact.org/





     Office Locations:

PO Box 58
Hingham, MA 02043

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    The mission of the Catalytic Impact Foundation is to accelerate innovations in life sciences and healthcare, funding companies that address unmet medical needs. By employing the discipline of traditional venture capital, the foundation invests philanthropic capital to support companies with transformative, life-sustaining technologies. Catalytic focuses its investments in areas where the need is great, but funding is weak: 1. Children's Health, 2. Brain and Mental Health, 3. Women's Health, 4. Rare Diseases, 5. Health Equity, and 6. Aging. The Catalytic Impact Foundation believes that diversity drives innovation, and innovation suffers when 50 percent of the population struggles to access capital. The foundation actively looks for, and invests in, women-led companies with transformative technologies addressing unmet healthcare needs. Most of CIF's investments are in the pre-seed or seed stage (55%), with another 33% in Series A. CIF only makes equity investments (not grants), and is open to all traditional financing structures, including convertible notes, SAFE notes, or equity.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Rachel Butler President
    Richard Lipkin Co-Founder
    Robert I. Wolk Board Chair

     

    Portfolio companies include:


      Antimicrobial Therapeutics


      Cellevolve


      Chameleon Biosciences


      Deck Therapeutics


      Lucy Therapeutics


      Microbion


      Oncoheroes Biosciences


      Orange Grove Bio


      Pison


      Sonavi Labs


      Starlight Cardiovascular


      Stingray Therapeutics


      X-Therma
        web link


     

    Recent News: